Chugai Pharmaceutical Co (Chugai Pharmaceutical Co) FCF Margin % : 37.30% (As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Chugai Pharmaceutical Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Chugai Pharmaceutical Co's Free Cash Flow for the three months ended in Mar. 2024 was $590 Mil. Chugai Pharmaceutical Co's Revenue for the three months ended in Mar. 2024 was $1,582 Mil. Therefore, Chugai Pharmaceutical Co's FCF Margin % for the quarter that ended in Mar. 2024 was 37.30%.

As of today, Chugai Pharmaceutical Co's current FCF Yield % is 4.41%.

The historical rank and industry rank for Chugai Pharmaceutical Co's FCF Margin % or its related term are showing as below:

CHGCY' s FCF Margin % Range Over the Past 10 Years
Min: 0.48 Med: 12.75 Max: 31.36
Current: 31.36

During the past 13 years, the highest FCF Margin % of Chugai Pharmaceutical Co was 31.36%. The lowest was 0.48%. And the median was 12.75%.

CHGCY's FCF Margin % is ranked better than
96% of 1026 companies
in the Drug Manufacturers industry
Industry Median: -0.68 vs CHGCY: 31.36

Chugai Pharmaceutical Co FCF Margin % Historical Data

The historical data trend for Chugai Pharmaceutical Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chugai Pharmaceutical Co FCF Margin % Chart

Chugai Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

21.20

18.25

20.68

13.68

30.20

Chugai Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															32.21	40.08	8.50	38.71	37.30

Competitive Comparison of Chugai Pharmaceutical Co's FCF Margin %

For the Drug Manufacturers - General subindustry, Chugai Pharmaceutical Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chugai Pharmaceutical Co's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chugai Pharmaceutical Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Chugai Pharmaceutical Co's FCF Margin % falls into.

Chugai Pharmaceutical Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Chugai Pharmaceutical Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	2331.32	/	7718.818
	=	30.20 %

Chugai Pharmaceutical Co's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	589.907	/	1581.573
	=	37.30 %

Chugai Pharmaceutical Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Chugai Pharmaceutical Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Chugai Pharmaceutical Co (Chugai Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chugai Pharmaceutical Co Ltd (OTCPK:CHGCY) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

CHGCF:USA 4519:Japan CUP:Germany

Address

1-1 Nihonbashi-Muromachi 2-Chome, Nihonbashi Mitsui Tower (Reception15F), Chuo-ku, Tokyo, JPN, 103-8324

Website

http://www.chugai-pharm.co.jp

Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding Ltd, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra for hemophilia A patients and tocilizumab for treating rheumatoid arthritis and COVID-19.

Chugai Pharmaceutical Co (Chugai Pharmaceutical Co) Headlines

From GuruFocus

T. Rowe Price Japan Fund Makes 4 New Buys in 3rd Quarter

By David Goodloe David Goodloe • 10-19-2016

Chugai and Biofourmis Enter into New Partnership Focused on Data-Driven Virtual Care for Endometriosis-Related Pain

By PRNewswire PRNewswire • 03-02-2023

Jean Hynes Adds to Chugai Pharmaceutical Stake

By Kyle Ferguson Kyle Ferguson • 08-22-2016

Chugai and Biofourmis Partner to Develop an Objective Assessment of Pain Using Digital Technology

By PRNewswire PRNewswire • 07-22-2020

Chugai and Biofourmis Partner to Develop an Objective Assessment of Pain Using Digital Technology

By PRNewswire PRNewswire • 07-22-2020

T. Rowe Price Japan Fund Comments on Chugai Pharmaceutical

By Sydnee Gatewood Sydnee Gatewood • 06-19-2020